Abstract: International audience; Background. The emerging zoonotic paramyxovirus Nipah virus (NiV) causes severe respiratory and neurological disease inhumans, with high fatality rates. Nipah virus can be transmitted via person-to-person contact, posing a high risk for epidemic outbreaks. However, a broadly applicable approach for human NiV outbreaks in field settings is lacking.Methods. We engineered new antiviral lipopeptides and analyzed in vitro fusion inhibition to identify an optimal candidate forprophylaxis of NiV infection in the lower respirato...
(read more)
Topics: 
Virology
Immunology